Jun 22, 2026 06:35AM
Jun 2, 2026 04:28AM
May 19, 2026 06:48AM
May 14, 2026 04:45AM
May 13, 2026 04:05PM
May 13, 2026 07:44AM
Apr 24, 2026 05:08AM Goldman Sachs Upgrades Altimmune (ALT) to Neutral
Mar 27, 2026 10:53AM
Mar 18, 2026 03:53PM
Mar 17, 2026 06:46AM
Mar 5, 2026 11:31AM
Mar 5, 2026 07:02AM
Jan 27, 2026 06:32AM
Dec 19, 2025 06:30AM Altimmune reports positive 48-week data for MASH drug pemvidutide
Nov 12, 2025 04:47AM
Nov 11, 2025 08:52AM
Nov 7, 2025 08:06AM
Nov 6, 2025 07:02AM
Oct 20, 2025 06:56AM
Sep 19, 2025 06:50AM
Aug 12, 2025 07:00AM Altimmune, Inc. (ALT) Tops Q2 EPS by 4c
Aug 11, 2025 07:30AM
Jul 10, 2025 04:14AM
Jul 10, 2025 02:22AM
Jul 9, 2025 07:30AM
Jun 27, 2025 10:02AM
Jun 27, 2025 06:52AM
Jun 26, 2025 07:02AM Altimmune (ALT) Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide
Jun 5, 2025 04:24AM
Jun 2, 2025 07:07AM
May 19, 2025 07:31AM
May 14, 2025 07:37AM
May 13, 2025 07:02AM
May 13, 2025 07:01AM
May 12, 2025 07:53AM Stifel Reiterates Buy Rating on Altimmune (ALT)
Apr 23, 2025 04:15AM
Apr 4, 2025 06:42AM
Apr 2, 2025 04:38AM
Mar 16, 2025 04:00AM
Mar 14, 2025 09:05AM
Mar 14, 2025 04:06AM
Mar 4, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Altimmune (ALT)
Feb 27, 2025 04:59PM
Feb 27, 2025 07:02AM
Feb 6, 2025 06:42AM
Jan 7, 2025 04:06PM
Jan 3, 2025 08:23AM
Dec 19, 2024 07:30AM
Nov 15, 2024 11:01AM Altimmune (ALT) Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease
Nov 12, 2024 07:02AM

416,181 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All